{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:11:07Z","timestamp":1771463467444,"version":"3.50.1"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Aplastic anemia (AA), myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML) exhibit complex pathogenic mechanisms and interrelated characteristics. We aimed to identify the common hub genes, establishing a foundation for preventing disease progression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We selected relevant datasets from the Gene Expression Omnibus(GEO) database for differential gene expression, gene set enrichment, and weighted gene co-expression network analyses to identify hub genes, and then validated them. Subsequent analyses included immune infiltration analysis, single-cell sequencing, and cell communication analysis. We performed Mendelian randomization to screen inflammatory factors and immune cells. We used RT-qPCR, Enzyme - Linked Immunosorbent Assay(ELISA), and cell proliferation assays to validate the identified hub genes, their relationship with cellular communication mediators and inflammatory factors, and their impact on cellular function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>POLG and MAP2K7 were identified as common hub genes, with low expression observed across AA, MDS, and AML. There were distinct immune differentials among these diseases, with an enhanced correlation between immune cells and hub genes as the disease progressed. Macrophage Migration Inhibitory Factor(MIF) emerged as a key mediator of cellular communication. We identified 20 regulatory pathways of immune cells and inflammatory factors across different disease stages. <jats:italic>In vitro<\/jats:italic> validation confirmed low expression of the hub genes, which were inversely correlated with MIF and inflammatory factors, though they showed no significant impact on cell proliferation or migration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>POLG and MAP2K7 demonstrate crucial roles in the progression from AA to MDS and, ultimately, to AML. These genes regulate more than 20 immune regulatory pathways through MIF-mediated communication, thereby influencing disease progression.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1547289","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T05:26:57Z","timestamp":1746682017000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of common hub genes and construction of immune regulatory networks in aplastic anemia, myelodysplastic syndromes, and acute myeloid leukemia"],"prefix":"10.3389","volume":"16","author":[{"given":"Mingliang","family":"Shan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiumei","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.844978","article-title":"A deep learning model for the automatic recognition of aplastic anemia, myelodysplastic syndromes, and acute myeloid leukemia based on bone marrow smear","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26310","article-title":"Diagnostic work-up for severe aplastic anemia in children: Consensus of the North American Pediatric Aplastic Anemia Consortium","volume":"96","author":"Shimano","year":"2021","journal-title":"Am J Hematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)66515-4","article-title":"Aplastic anaemia","volume":"365","author":"Brodsky","year":"2005","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.3.271","article-title":"Acquired aplastic anemia","volume":"282","author":"Young","year":"1999","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(88)90388-1","article-title":"Criteria for severe aplastic anaemia","volume":"1","author":"Camitta","year":"1988","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11689","article-title":"Aplastic anemia, cellular and molecular aspects","volume":"45","author":"Javan","year":"2021","journal-title":"Cell Biol Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7199\/ped.oncall.2012.32","article-title":"Aplastic anemia (Fanconi`s anemia)","volume":"9","author":"Kumar","year":"2012","journal-title":"Pediatr Oncall"},{"key":"B8","unstructured":"Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis - PubMed"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2019.1642548","article-title":"Pathogenesis of aplastic anemia","volume":"24","author":"Wang","year":"2019","journal-title":"Hematology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(95)91273-8","article-title":"Aplastic anaemia","volume":"346","author":"Young","year":"1995","journal-title":"Lancet"},{"key":"B11","article-title":"Mechanisms in aplastic anaemia","volume":"2","year":"1976","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-693481","article-title":"How I treat acquired aplastic anemia","volume":"129","author":"Bacigalupo","year":"2017","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v100.3.786","article-title":"Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children","volume":"100","author":"Kojima","year":"2002","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-767731","article-title":"Origins of myelodysplastic syndromes after aplastic anemia","volume":"130","author":"Negoro","year":"2017","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1182\/blood.2019000940","article-title":"Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria","volume":"136","author":"Sun","year":"2020","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26984","article-title":"Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Garcia-Manero","year":"2023","journal-title":"Am J Hematol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2047","article-title":"Myelodysplastic syndromes: the complexity of stem-cell diseases","volume":"7","author":"Corey","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/hs9.0000000000000253","article-title":"Myelodysplastic syndromes","volume":"3","author":"Ungerstedt","year":"2019","journal-title":"HemaSphere"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1904794","article-title":"Myelodysplastic syndromes","volume":"383","author":"Cazzola","year":"2020","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-078139","article-title":"Myelodysplastic syndromes","volume":"111","author":"Nimer","year":"2008","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.5696","article-title":"Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes","volume":"25","author":"Malcovati","year":"2007","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-522136","article-title":"Recent developments in myelodysplastic syndromes","volume":"124","author":"Bejar","year":"2014","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.6004\/jnccn.2011.0005","article-title":"Myelodysplastic syndromes","volume":"9","author":"Greenberg","year":"2011","journal-title":"J Natl Compr Cancer Netw"},{"key":"B24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"D\u00f6hner","year":"2010","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24246","article-title":"Acute myeloid leukemia\u2014Major progress over four decades and glimpses into the future","volume":"91","author":"Kantarjian","year":"2016","journal-title":"Am J Hematol"},{"key":"B27","unstructured":"Biochemical mechanisms implemented by human acute myeloid leukemia cells to suppress host immune surveillance"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1172\/JCI129204","article-title":"Immune escape and immunotherapy of acute myeloid leukemia","volume":"130","author":"Vago","year":"2020","journal-title":"J Clin Invest"},{"key":"B29","unstructured":"Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment - PubMed"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052863","article-title":"Application of high throughput technologies in the development of acute myeloid leukemia therapy: challenges and progress","volume":"23","author":"Xiang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1182\/hem.v13.5.6435","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"13","author":"Moss","year":"2016","journal-title":"Hematol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13045-017-0409-z","article-title":"Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia","volume":"10","author":"Li","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01084-2","article-title":"New treatments for acute myeloid leukemia: how much has changed","volume":"35","author":"Estey","year":"2020","journal-title":"Leukemia"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2014update","volume":"41","author":"Barrett","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B35","unstructured":"Computing cell state discriminates the aberrant hematopoiesis and activated microenvironment in Myelodysplastic syndrome (MDS) through a single cell genomic study - PMC"},{"key":"B36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1182\/blood.2020008966","article-title":"Single-cell transcriptomics dissects hematopoietic cell destruction and T-cell engagement in aplastic anemia","volume":"138","author":"Zhu","year":"2021","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.115660","article-title":"Mendelian-randomization study reveals causal relationships between nitrogen dioxide and gut microbiota","volume":"267","author":"Yang","year":"2023","journal-title":"Ecotoxicol Environ Saf"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2013.09.007","article-title":"Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclooxygenase-2 expression in gastric cancer","volume":"21","author":"Zhang","year":"2014","journal-title":"Phytomedicine"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.00653","article-title":"Proliferating cell nuclear antigen (PCNA): a dancer with many partners","volume":"116","author":"Maga","year":"2003","journal-title":"J Cell Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711620403","article-title":"Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasms","volume":"162","author":"Hall","year":"1990","journal-title":"J Pathol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.07.002","article-title":"Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy","volume":"122","author":"Pattingre","year":"2005","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210220","article-title":"The bcl-2 apoptotic switch in cancer development and therapy","volume":"26","author":"Adams","year":"2007","journal-title":"Oncogene"},{"key":"B48","article-title":"Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia","volume":"141","author":"Poulsom","year":"1992","journal-title":"PubMed"},{"key":"B49","article-title":"Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis","volume":"151","author":"Luca","year":"1997","journal-title":"PubMed"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05621-2","article-title":"Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia following immunosuppressive therapy for aplastic anemia is more common as compared to allogeneic stem cell transplantation with a negative impact on survival","volume":"103","author":"Chattopadhyay","year":"2024","journal-title":"Ann Hematol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.02.017","article-title":"Mitochondrial DNA maintenance defects","volume":"1863","author":"El-Hattab","year":"2017","journal-title":"Biochim Biophys Acta (BBA)  Mol Basis Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41582-018-0101-0","article-title":"POLG-related disorders and their neurological manifestations","volume":"15","author":"Rahman","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"a011395","DOI":"10.1101\/cshperspect.a011395","article-title":"Clinical and molecular features of POLG-related mitochondrial disease","volume":"5","author":"Stumpf","year":"2013","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.1038\/ncomms7494","article-title":"MtDNA mutagenesis impairs elimination of mitochondria during erythroid maturation leading to enhanced erythrocyte destruction","volume":"6","author":"Ahlqvist","year":"2015","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-169474","article-title":"Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction","volume":"114","author":"Chen","year":"2009","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07260-z","article-title":"Ancestral allele of DNA polymerase gamma modifies antiviral tolerance","volume":"628","author":"Kang","year":"2024","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129127","article-title":"Pharmacological inhibition of MAP2K7 induces apoptosis and cell cycle arrest in T-cell acute lymphoblastic leukemia","volume":"134","author":"Chen","year":"2019","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v124.21.3569.3569","article-title":"Kr\u00fcppel-like factor 4 (KLF4) suppresses T-cell acute lymphoblastic leukemia by inhibiting expression of MAP2K7 and expansion of leukemia initiating cells","volume":"124","author":"Shen","year":"2014","journal-title":"Blood"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.28040","article-title":"Inhibition of the MAP2K7-JNK pathway with 5Z-7-oxozeaenol induces apoptosis in T-cell acute lymphoblastic leukemia","volume":"12","author":"Chen","year":"2021","journal-title":"Oncotarget"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008548","article-title":"Antileukemic properties of the kinase inhibitor OTSSP167 in T-cell acute lymphoblastic leukemia","volume":"7","author":"Bridges","year":"2022","journal-title":"Blood Adv"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.339","article-title":"Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway","volume":"31","author":"Shen","year":"2017","journal-title":"Leukemia"},{"key":"B62","doi-asserted-by":"publisher","first-page":"73366","DOI":"10.18632\/oncotarget.20672","article-title":"KLF4 represses MAP2K7 signaling in T-ALL","volume":"8","author":"Lacorazza","year":"2017","journal-title":"Oncotarget"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e0053223","DOI":"10.1128\/jvi.00532-23","article-title":"Zebrafish MAP2K7 simultaneously enhances host IRF7 stability and degrades spring viremia of carp virus P protein via ubiquitination pathway","volume":"97","author":"Zhang","year":"2023","journal-title":"J Virol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa462","article-title":"Downregulated gene expression spectrum and immune responses changed during the disease progression in patients with COVID-19","volume":"71","author":"Ouyang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2022.11.004","article-title":"Contribution of metabolic abnormalities to acute myeloid leukemia pathogenesis","volume":"33","author":"Egan","year":"2023","journal-title":"Trends Cell Biol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1195392","article-title":"Aggrephagy-related patterns in tumor microenvironment, prognosis, and immunotherapy for acute myeloid leukemia: a comprehensive single-cell RNA sequencing analysis","volume":"13","author":"Y","year":"2023","journal-title":"Front Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-1095","article-title":"MIF-induced stromal PKC\u03b2\/IL8 is essential in human acute myeloid leukemia","volume":"77","author":"Abdul-Aziz","year":"2017","journal-title":"Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.10.003","article-title":"Overexpression of GYS1, MIF, and MYC is associated with adverse outcome and poor response to azacitidine in myelodysplastic syndromes and acute myeloid leukemia","volume":"15","author":"Falantes","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nm1567","article-title":"MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.012511599","article-title":"Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response","volume":"99","author":"Mitchell","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210318","article-title":"Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5\/JAB1 in the control of autocrine MIF activity","volume":"26","author":"Lue","year":"2007","journal-title":"Oncogene"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1006\/scbi.2000.0328","article-title":"Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF)","volume":"10","author":"Mitchell","year":"2000","journal-title":"Semin Cancer Biol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.108","article-title":"Cytokines and chemokines","volume":"111","author":"Borish","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2023.102286","article-title":"Cytokine-mediated STAT-dependent pathways underpinning human B-cell differentiation and function","volume":"81","author":"Tangye","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1006\/frne.1998.0176","article-title":"Pathophysiological role of the cytokine network in the anterior pituitary gland","volume":"20","author":"Arzt","year":"1999","journal-title":"Front Neuroendocrinol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.fertnstert.2015.08.011","article-title":"Role of inflammatory mediators in patients with recurrent pregnancy loss","volume":"104","author":"Comba","year":"2015","journal-title":"Fertil Steril"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/0753-3322(94)90005-1","article-title":"Cytokines and macrophages","volume":"48","author":"Cavaillon","year":"1994","journal-title":"BioMed Pharmacother"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2017.12.010","article-title":"MIF promotes a differential Th1\/Th2\/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-\u03b1 in PBMC from active SLE patients","volume":"324","author":"De la Cruz-Mosso","year":"2018","journal-title":"Cell Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket287","article-title":"Articular adipose tissue resident macrophages in rheumatoid arthritis patients: potential contribution to local abnormalities","volume":"52","author":"Kontny","year":"2013","journal-title":"Rheumatol (Oxford)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/srep10942","article-title":"The serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes","volume":"5","author":"Guo","year":"2015","journal-title":"Sci Rep"},{"key":"B81","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00262-024-03746-x","article-title":"Altered expression of cytokines, chemokines, growth factors, and soluble receptors in patients with colorectal cancer, and correlation with treatment outcome","volume":"73","author":"Stayoussef","year":"2024","journal-title":"Cancer Immunol Immunother: CII"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2016.1241709","article-title":"Systemic inflammatory immune signatures in a patient with CRB1 linked retinal dystrophy","volume":"12","author":"Verhagen","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.2174\/1871523020666210920100707","article-title":"Inflammation in asthma pathogenesis: role of T cells, macrophages, epithelial cells and type 2 inflammation","volume":"20","author":"Alobaidi","year":"2021","journal-title":"Antiinflamm Antiallergy Agents Med Chem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1547289\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T05:27:05Z","timestamp":1746682025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1547289\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":83,"alternative-id":["10.3389\/fimmu.2025.1547289"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1547289","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"article-number":"1547289"}}